Bottom line: Companies must prioritize cyber resilience around the continuity of medicine value chains to protect against supply chain attacks.
What's happening: In 2022, supply chain attacks on pharmaceutical companies increased by 35%, with attacks on companies like Eli Lilly and Novartis, affecting over 2,000 employees and resulting in a reported $12.3 million in damages. The attacks targeted the continuity of medicine value chains, which includes manufacturing, distribution, and dispensing.
What to do: Companies should implement robust cybersecurity measures to protect against supply chain attacks, such as implementing robust access controls, monitoring supply chain partners and vendors, and conducting regular vulnerability assessments.